Trials / Completed
CompletedNCT03335085
Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences
Long-term Consequences of Childhood Adversity: Exploring Stress Responsive Molecular Pathways and Psychobiological Intervention Models
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Ruhr University of Bochum · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates whether intranasal administration of a single dose of oxytocin improves the ability to recognize emotional states. In a cross-over design, half of the participants first received oxytocin, the other half first received placebo.
Detailed description
Adverse childhood experience such as neglect or abuse can lead to long-term deficits in emotion processing abilities, and these effects might be mediated via alterations in oxytocin production or sensitivity. The goal of this study was to test whether emotion recognition abilities and empathy might be improved by intranasal oxytocin administration in adults with a history of childhood maltreatment. In a double-blind, placebo-controlled experiment with a crossover design, we assessed the performance of 40 healthy participants with a history of childhood adversity on the Reading the Mind in the Eyes Test (RMET) and an emotion recognition task under 24 IU oxytocin vs. placebo and compared them to a control group of 40 matched individuals without traumatic childhood experiences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | |
| OTHER | Placebo |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-03-23
- Completion
- 2013-11-05
- First posted
- 2017-11-07
- Last updated
- 2017-11-07
Source: ClinicalTrials.gov record NCT03335085. Inclusion in this directory is not an endorsement.